Building a Foundation: Understanding Primary Hyperoxaluria
At a Glance
Primary hyperoxaluria is an inherited metabolic disorder that starts in the liver, where a faulty enzyme causes excess oxalate. The oxalate forms calcium oxalate crystals that can cause kidney stones, crystal deposits in kidney tissue, and kidney damage, so specialist evaluation is important.
Receiving a diagnosis of Primary Hyperoxaluria (PH) often marks the end of a long and confusing search for answers. For many families, this moment is a complex mix of relief—finally knowing why your child or you have been struggling with kidney stones or health issues—and a deep, understandable fear of what a rare genetic diagnosis means for the future [1][2]. It is important to know that you are not alone in this journey, and that having a clear diagnosis means you can finally start the right treatments.
A Tale of Two Organs: The Liver and the Kidney
Although PH is often discovered because of kidney problems, it is fundamentally a metabolic disorder of the liver [1]. In a healthy body, the liver uses specific enzymes (proteins that act as tools for chemical reactions) to break down waste products. One of these waste products is called glyoxylate [1][3].
In a person with PH, one of these liver enzymes is either missing or not working correctly due to a genetic change [1]. Because the liver cannot process glyoxylate normally, it turns it into a substance called oxalate instead [1][4].
- The Overproduction: The liver produces excessive amounts of oxalate, which then enters the bloodstream.
- The Filter: The kidneys are responsible for filtering oxalate out of the blood and into the urine [5].
- The Damage: Oxalate is very “sticky” when it meets calcium. In the kidneys, it binds with calcium to form calcium oxalate crystals [3][5].
These crystals can form painful kidney stones, but they can also cause nephrocalcinosis—a condition where crystals deposit directly into the kidney tissue itself, much like sand getting stuck in a delicate filter [5][6]. Over time, this constant crystallization can scar the kidneys and reduce their ability to function.
How Rare is PH?
PH is an ultra-rare condition. Recent genetic research estimates that the combined prevalence of all types of PH is approximately 1 in 59,000 people [7][8]. To put that in perspective, in a city of one million people, only about 17 might have this genetic condition.
Because it is so rare, most local doctors or general pediatricians may have never seen a case in their entire career. This lack of experience can lead to a “diagnostic odyssey,” where it takes years to get the right answer [1][2].
Common Misunderstandings at Diagnosis
The journey to a PH diagnosis is frequently paved with misdirections. Because the symptoms—like kidney stones—look like more common issues, PH is often missed at first. Some common hurdles include:
- The “Ordinary Stone” Label: Doctors may assume a patient just has “normal” kidney stones caused by diet or dehydration. However, stones in PH are often made of calcium oxalate monohydrate, a specific type that should raise immediate suspicion in young patients [6].
- The Normal Urine Trap: A common and dangerous misunderstanding is that a “normal” urine oxalate test means someone doesn’t have PH [3]. If the kidneys are already significantly damaged, they can no longer filter oxalate into the urine efficiently. In these cases, the urine oxalate levels might look low or normal even though the levels in the blood (plasma oxalate) are dangerously high [3][9].
- Missing the Liver Link: Because the symptoms are in the kidney, many people focus only on the kidneys. It is vital to remember that the metabolic process originates in the liver [1].
Validating the “Diagnosis Shock”
It is completely normal to feel overwhelmed. You may have been told for years to “drink more water” or “eat less spinach,” only to find out now that the cause is a permanent genetic condition [10].
The transition from treating a “common” problem to managing a rare metabolic disease requires a shift in mindset. You are no longer just managing stones; you are managing a lifelong metabolic process. Finding a specialized care team—usually centered around a nephrologist with expertise in rare inherited metabolic diseases, supported by a renal dietitian and genetic counselor—is the most important next step [1][11].
Common questions in this guide
What is primary hyperoxaluria?
Why does primary hyperoxaluria cause kidney stones?
Can a normal urine oxalate test rule out primary hyperoxaluria?
What type of kidney stone can point to primary hyperoxaluria?
Which specialists should be involved in primary hyperoxaluria care?
What should family members know after a primary hyperoxaluria diagnosis?
Is primary hyperoxaluria caused by dehydration or diet?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Primary hyperoxaluria.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the specific genetic subtype of PH that was found, and can you explain the exact mutation or 'variant' identified?
- 2.Since this is a rare metabolic disorder, how many other patients with PH have you or this clinic treated?
- 3.Given that the liver and kidneys are both involved, will my care team include a metabolic nephrologist and a genetic specialist?
- 4.Has a 24-hour urine oxalate test been performed, and if so, how do these levels compare to a healthy person's range?
- 5.If kidney function is currently decreased, has a plasma oxalate test been scheduled to check the levels in the blood?
- 6.What specific steps should we take now to screen our other children or close family members?
References
References (11)
- 1
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope.
Groothoff JW, Metry E, Deesker L, et al.
Nature reviews. Nephrology 2023; (19(3)):194-211 doi:10.1038/s41581-022-00661-1.
PMID: 36604599 - 2
Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up.
Garrelfs SF, Rumsby G, Peters-Sengers H, et al.
Kidney international 2019; (96(6)):1389-1399 doi:10.1016/j.kint.2019.08.018.
PMID: 31685312 - 3
Clinical Approaches and Emerging Therapeutic Horizons in Primary Hyperoxaluria.
Martínez-Galindo R, Campuzano-Pérez M, Konstantouli A, et al.
Journal of clinical medicine 2026; (15(3)) doi:10.3390/jcm15030940.
PMID: 41682620 - 4
Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1.
Castello R, Borzone R, D'Aria S, et al.
Gene therapy 2016; (23(2)):129-34 doi:10.1038/gt.2015.107.
PMID: 26609667 - 5
Primary and secondary hyperoxaluria: Understanding the enigma.
Bhasin B, Ürekli HM, Atta MG
World journal of nephrology 2015; (4(2)):235-44 doi:10.5527/wjn.v4.i2.235.
PMID: 25949937 - 6
Distinguishing characteristics of pediatric patients with primary hyperoxaluria type 1 in PEDSnet.
Tasian GE, Dickinson K, Park G, et al.
Journal of pediatric urology 2024; (20(1)):88.e1-88.e9 doi:10.1016/j.jpurol.2023.10.001.
PMID: 37848358 - 7
Global genetic prevalence estimates of primary hyperoxaluria are greater than previously reported.
Mandrile G, Rumsby G, Sciannameo V, et al.
Clinical kidney journal 2025; (18(7)):sfaf194 doi:10.1093/ckj/sfaf194.
PMID: 40873808 - 8
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.
Hopp K, Cogal AG, Bergstralh EJ, et al.
Journal of the American Society of Nephrology : JASN 2015; (26(10)):2559-70 doi:10.1681/ASN.2014070698.
PMID: 25644115 - 9
Primary Hyperoxaluria Type 1 Diagnosed After Kidney Transplantation in the Absence of Classical Features.
Sultan R, Alsayed-Ahmad ZA, Shheibar AR, et al.
Case reports in nephrology 2026; (2026()):4378614 doi:10.1155/crin/4378614.
PMID: 42670475 - 10
Late diagnosis of primary hyperoxaluria type III.
Richard E, Blouin JM, Harambat J, et al.
Annals of clinical biochemistry 2017; (54(3)):406-411 doi:10.1177/0004563216677101.
PMID: 27742850 - 11
Treatment of primary hyperoxaluria type 1.
Gupta A, Somers MJG, Baum MA
Clinical kidney journal 2022; (15(Suppl 1)):i9-i13 doi:10.1093/ckj/sfab232.
PMID: 35592620
This page explains how primary hyperoxaluria affects the liver and kidneys for informational purposes only and does not constitute medical advice. Your nephrologist, metabolic specialist, and genetic counselor should interpret your test results and recommend care for your situation.